These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32814845)

  • 1. Quantifying observational evidence for risk of dementia following androgen deprivation therapy for prostate cancer: an updated systematic review and meta-analysis.
    Cui H; Wang Y; Li F; He G; Jiang Z; Gang X; Wang G
    Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):15-23. PubMed ID: 32814845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis.
    Nead KT; Sinha S; Nguyen PL
    Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):259-264. PubMed ID: 28349979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: a systematic review and meta-analysis.
    Guo Z; Huang Y; Gong L; Gan S; Chan FL; Gu C; Xiang S; Wang S
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):451-460. PubMed ID: 29988099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.
    Bosco C; Bosnyak Z; Malmberg A; Adolfsson J; Keating NL; Van Hemelrijck M
    Eur Urol; 2015 Sep; 68(3):386-96. PubMed ID: 25484142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke related to androgen deprivation therapy for prostate cancer: a meta-analysis and systematic review.
    Meng F; Zhu S; Zhao J; Vados L; Wang L; Zhao Y; Zhao D; Niu Y
    BMC Cancer; 2016 Mar; 16():180. PubMed ID: 26940836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in Taiwan.
    Huang WK; Liu CH; Pang ST; Liu JR; Chang JW; Liaw CC; Hsu CL; Lin YC; See LC
    JAMA Netw Open; 2020 Aug; 3(8):e2015189. PubMed ID: 32865575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen Deprivation Therapy and the Risk of Stroke in Patients with Prostate Cancer: An Updated Systematic Review and Meta-Analysis.
    Liu R; Zhou J; Xia S; Li T
    Urol Int; 2020; 104(3-4):214-221. PubMed ID: 31747673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study.
    Kao LT; Lin HC; Chung SD; Huang CY
    Asian J Androl; 2017; 19(4):414-417. PubMed ID: 27232853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism.
    Klil-Drori AJ; Yin H; Tagalakis V; Aprikian A; Azoulay L
    Eur Urol; 2016 Jul; 70(1):56-61. PubMed ID: 26138040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of androgen deprivation therapy and depression in the treatment of prostate cancer: A systematic review and meta-analysis.
    Nead KT; Sinha S; Yang DD; Nguyen PL
    Urol Oncol; 2017 Nov; 35(11):664.e1-664.e9. PubMed ID: 28803700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary role of androgen deprivation therapy for prostate cancer.
    Pagliarulo V; Bracarda S; Eisenberger MA; Mottet N; Schröder FH; Sternberg CN; Studer UE
    Eur Urol; 2012 Jan; 61(1):11-25. PubMed ID: 21871711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis.
    Wang H; Sun X; Zhao L; Chen X; Zhao J
    J Diabetes Investig; 2016 Jul; 7(4):629-36. PubMed ID: 27181717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Risk of New Onset Dementia and/or Alzheimer Disease among Patients with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis.
    Sari Motlagh R; Quhal F; Mori K; Miura N; Aydh A; Laukhtina E; Pradere B; Karakiewicz PI; Enikeev DV; Deuker M; Shariat SF
    J Urol; 2021 Jan; 205(1):60-67. PubMed ID: 32856962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer.
    Lonergan PE; Washington SL; Cowan JE; Zhao S; Broering JM; Cooperberg MR; Carroll PR
    J Urol; 2022 Apr; 207(4):832-840. PubMed ID: 34854749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer.
    Liu JM; Chen TH; Chuang HC; Wu CT; Hsu RJ
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):276-283. PubMed ID: 30337635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer.
    Beckmann K; Garmo H; Adolfsson J; Bosco C; Johansson E; Robinson D; Holmberg L; Stattin P; Van Hemelrijck M
    Eur Urol; 2019 Apr; 75(4):676-683. PubMed ID: 30497883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
    Tucci M; Bertaglia V; Vignani F; Buttigliero C; Fiori C; Porpiglia F; Scagliotti GV; Di Maio M
    Eur Urol; 2016 Apr; 69(4):563-573. PubMed ID: 26422676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model.
    Hong JH; Huang CY; Chang CH; Muo CH; Jaw FS; Lu YC; Chung CJ
    Cancer Epidemiol; 2020 Feb; 64():101657. PubMed ID: 31918180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of dementia following androgen deprivation therapy for treatment of prostate cancer.
    Krasnova A; Epstein M; Marchese M; Dickerman BA; Cole AP; Lipsitz SR; Nguyen PL; Kibel AS; Choueiri TK; Basaria S; Mucci LA; Sun M; Trinh QD
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):410-418. PubMed ID: 31784699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen deprivation therapy for prostate cancer and risk of dementia.
    Robinson D; Garmo H; Van Hemelrijck M; Damber JE; Bratt O; Holmberg L; Wahlund LO; Stattin P; Adolfsson J
    BJU Int; 2019 Jul; 124(1):87-92. PubMed ID: 30637900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.